Mélanie Thill-Tayara
Dechert (Paris)
Lawyer (Partner)
Mélanie Thill-Tayara is partner at Dechert LLP in Paris. She is a competition lawyer based in Paris where she heads the French and European competition law department. She specialises in a variety of sectors including consumer goods, pharmaceuticals and medical devices, chemicals, leisure and luxury goods. Mélanie focuses on various aspects of EU and French competition law. She has acquired a strong reputation as a litigator and has been involved in landmark cases, for example in the field of essential facilities, dominance abuses in the pharma sector and information exchange systems. Melanie has represented major French and international companies in merger notifications before French and EU competition authorities, as well as in multi-jurisdictional filings. Mélanie is a member of the International Bar Association, the Association Française de l’Etude de la Concurrence and the Studienvereinigung Kartellrecht. She is a member of the board and executive committee of the Association des Avocats Pratiquant le Droit de la Concurrence (APDC). Mélanie regularly contributes to legal reviews as well as the legal pages of the financial and economic press. She is also a regular speaker at various competition law or sector-specialised conferences. Before joining Dechert, Mélanie spent 20 years as partner of another leading international law firm. Prior to that she worked for the European Commission, at the Directorate General for Competition for three years, during which she acted in historic cases such as the cement cartels. Mélanie holds a DEA (post-graduate degree) in business law and private international law from the University of Paris I Panthéon-Sorbonne, a Maîtrise (master’s degree) in International and European law, a Diploma from the Centre Universitaire d’Etudes Communautaires and a Diploma of Political Sciences from the University of Munich. She was admitted to the Paris Bar in 1987.
Distinctions
Linked authors
Frédéric Jenny
ESSEC Business School (Cergy)
Eric David
Kramer Levin Naftalis & Frankel (Paris)
Emmanuelle Claudel
University Paris II Panthéon‑Assas
Carole Champalaune
Ministère de la Justice (Paris)
Marta Giner Asins
Norton Rose Fulbright (Paris)
Bruno Lasserre
French State Council (Paris)
Peter Freeman
UK Competition Appeal Tribunal (London)
Wouter Wils
European Commission (Brussels)
19354 | Conferences
Articles
2104 Bulletin
275
On 12 December 2018, the General Court (“Court”) partially annulled the European Commission’s decision of 9 July 2014 in the Servier case and consequently reduced Servier’s fine by more than 30%, from €330.99 million to €228.32 million. After the Lundbeck judgment of 8 September 2016, this second (...)
1352
The pharmaceutical sector stands out as being regularly on the radar of competition authorities throughout Europe, with no less than 7 decisions adopted within the last 18 months and multiple on-going investigations, covering a wide range of practices, from excessive pricing to pay for delay, refusal to supply and, more generally, commercial strategies implemented by pharmaceutical companies to delay generic or biosimilar entry.
88
The General Court of the European Union recently held, in Goldman Sachs v. Commission, that purely financial investors such as investment funds may be held jointly and severally liable for competition law violations implemented by their portfolio companies when they can exercise “decisive (...)
120
EU Court Orders New Assessment of Intel’s Rebates The Court of Justice of the European Union (CJEU) has quashed a ruling by the EU’s General Court which had upheld the European Commission’s (EC) 2009 finding of abuse of dominance by Intel Corporation Inc. Intel was fined €1.06 billion, a record at (...)
269
The new “Hamon Law” introducing French class actions and its effects on competition and distribution law Introduction In order to balance the powers of economic stakeholders, France has adopted a new consumer law, popularly known as the “Hamon Law”. The new statute, adopted by the French (...)
2374 Review
819
Interview réalisée par Mélanie Thill-Tayara, Associée, Dechert, Paris. Diplômé de l’Institut d’études politiques de Paris et de l’ENA, vous avez occupé plusieurs postes au sein de la DGCCRF, travaillé pour la Représentation permanente de la France auprès de l’Union européenne et, moins classique, avez (...)
946
The authors of this On-Topic focus on the latest developments in the pharmaceutical sector. According to Ms Thill-Tayara, author of the first contribution and lawyer with Dechert Paris, if the competition agencies’ activism is partly motivated by the need to limit the expenses of national health (...)
609
This third roundtable of the conference “New frontiers of Antitrust” (Paris, 21 February 2014) was dedicated to “European Competition Network 10 years after & EC Regulation 1/2003: Can cooperation be extended to merger control and advocacy?”. The objectives for the authors of this roundtable (...)
